Market sentiment regarding growth rates turned disappointing for companies like Profound Medical on August 1, 2025.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Market sentiment regarding growth rates turned disappointing for companies like Profound Medical on August 1, 2025.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Corporate activity in the medical device sector in August 2025 included M&A activity (Stryker/Inari Medical, ZimVie/Archimed), competition between Medtronic and Intuitive Surgical, and the impact of Trump administration tariffs and FDA reviews.Also in this story
- Lemaitre, Intuitive Surgical, and Teleflex are identified as companies operating in the surgical equipment segment.
- Medtronic invested in Orchestra BioMed's clinical programs and provided private placement funding, while Ligand also invested in the company.
- Obagi Medical and Waldencast plc completed an acquisition expanding into dermal fillers and granting US rights to the Saypha line, while Trump-era tariffs benefit AI stocks.
- Intuitive Surgical invested in Apreo Health, whose device competes with Zephyr Valve, which was previously approved by the FDA.
The entities involved
-
Market
Market located at ekwegbe
-
Profound Medical (Canada)
company in Mississauga, Canada
Nothing else this week.
Coverage
Newest first; wire copies grouped- Simply Wall St.The past five years for Profound Medical (TSE:PRN) investors has not been profitable We think intelligent long term investing is the way to go. But along the way some stocks are going to perform badl